López A, Zobolas J, Dumontier T, Aittokallio T (2026)
Multi-modal learning with incomplete data
Nat Commun, 17 (1)
DOI 10.1038/s41467-026-77212-w, PubMed 42811071

Yaqub S, Valberg M, Bjørnbeth BA, Angelsen JH, Brudvik KW, Eilertsen IA, Fristedt R, Fristrup CW, Gilg S, Hemmingsson O, Isaksson B, Juel IS, Knudsen AR, Larsen PN, Mortensen KE, Olsen IC, Sandström P, Sandvik OM, Sparrelid E, Taflin H, Lothe RA, Taskén K, ASAC Study Group (2026)
Aspirin after curative-intent treatment of colorectal cancer liver metastases (ASAC): a multicentre, phase 3, randomised, double-blind, placebo-controlled trial
Lancet Gastroenterol Hepatol (in press)
DOI 10.1016/S2468-1253(26)00260-8, PubMed 42777749

Avershina E, Birkeland EE, Bucher-Johannessen C, Rounge TB (2026)
CRISPR-Cas immune repertoires as an ecological record of bacterial interactions with mobile genetic elements in the human gut
Gut Microbes, 18 (1), 2734649
DOI 10.1080/19490976.2026.2734649, PubMed 42768305

Spangenberg H, Moe EL, Ødegård Fougner Ø, Sneeggen M, Pan M, Tan KW, Mateo Tortola M, Valenzuela C, Chang YY, Stenmark H, Raiborg C, Schink KO (2026)
A phosphoinositide and RAB switch controls early macropinocytosis
J Cell Sci (in press)
DOI 10.1242/jcs.265349, PubMed 42852846

Forcados C, Köksal H, Scherer E, Abrantes R, Dillard P, Duarte HO, Josefsson S, Gomes C, de Montlaur C, Hellesøy HTZ, Dunkel R, Smeland EB, Myklebust JH, Reis CA, McCormack E, Gelebart P, Inderberg EM, Wälchli S (2026)
Reviving low-affinity glycan-targeting CAR with combinatorial design
Cell Rep Med, 103108 (in press)
DOI 10.1016/j.xcrm.2026.103108, PubMed 42849448

Ree AH, Meltzer S, Flatmark K, Dueland S (2026)
Low-intensity induction chemotherapy before chemoradiotherapy for rectal cancer: 10-year overall survival in the LARC-RRP trial
Br J Radiol, 99 (1186), 2129-2136
DOI 10.1093/bjr/tqag133, PubMed 42233285